Quebec product in Bausch + Lomb’s portfolio
Sunday, August 4 2013 | 00 h 00 min | News
Mimetogen, a Montréal pharmaceutical company, has granted Bausch + Lomb an option to license MIM-D3, a treatment for dry-eye syndrome Without...
Read MoreEssilor acquires Transitions Optical
Monday, July 29 2013 | 00 h 00 min | News
Essilor International announced today that it has signed an agreement to acquire the 51% stake in Transitions Optical owned by PPG The French giant...
Read MoreBionic eye no longer mere science fiction
Wednesday, June 26 2013 | 00 h 00 min | News
In the 1970s, the American television series “The Six Million Dollar Man” chronicled the adventures of Steve Austin, a hero with a bionic eye...
Read MoreOcular dryness – the new Klondike for pharmaceutical companies
Monday, June 24 2013 | 00 h 00 min | News
The firm GlobalData predicts that the market value of drugs for dry eye syndrome will triple over the next 10 years According to GlobalData, this...
Read MoreHope in treatment for metastatic uveal melanoma
Wednesday, June 19 2013 | 00 h 00 min | News
For the first time, a drug has a real positive impact on patients with metastatic uveal melanoma, a disease often qualified as “untreatable” The...
Read More
